Pharm 2 Farm Update and Issue of Equity

RNS Number : 3525F

Remote Monitored Systems PLC

16 November 2020

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

16 November 2020

Remote Monitored Systems plc ("RMS" or the "Company")

Pharm 2 Farm Update and Issue of Equity

Remote Monitored Systems plc, the AIM quoted company, announces that it has retained the services of a consultant for business development and sales and marketing in relation to its wholly owned subsidiary Pharm 2 Farm Limited ("P2F"). The consultant who has been working with P2F for some time has elected to receive new ordinary shares in the Company in lieu of fees rather than the cash amount otherwise due. As a result of this, 10,000,000 new ordinary shares of 0.01 pence each, (the "Adviser Shares") will be issued to the consultant and application will be made for them to be admitted to trading on AIM ("Admission"). The Adviser Shares are subject to a lock-in until 1st August 2021. It is expected that Admission will become effective and dealings will commence at 8:00 a.m. on or around 20 November 2020.  

Total Voting Rights 

Following Admission of the Adviser Shares, the total issued share capital of the Company will consist of 1,583,270,231 ordinary shares. No shares were held in treasury at the date of this announcement. The total current voting rights in the Company is therefore 1,583,270,231.

The above figure of 1,583,270,231 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

ENDS

ENQUIRIES:

Remote Monitored Systems plc

Trevor Brown (Executive Director)                                                                        [phone]

Paul Ryan (Non-Executive Chairman)                                                                  [phone]

SP Angel Corporate Finance LLP                                                                          [phone]

Nominated Adviser and joint broker            

Stuart Gledhill

Caroline Rowe

Peterhouse Capital Limited                                                                                  [phone]

Joint broker 

Lucy Williams

Duncan Vasey

 

END

 

 

IOEEAFFSFSFEFAA